Suppr超能文献

药物和聚合物粒径对微波辐射原位非晶化的影响。

The influence of drug and polymer particle size on the in situ amorphization using microwave irradiation.

机构信息

Department of Pharmacy, University of Copenhagen, 2100 Copenhagen, Denmark.

Bioneer:FARMA, Department of Pharmacy, 2100 Copenhagen, Denmark.

出版信息

Eur J Pharm Biopharm. 2020 Apr;149:77-84. doi: 10.1016/j.ejpb.2020.01.019. Epub 2020 Feb 5.

Abstract

In this study, the impact of drug and polymer particle size on the in situ amorphization using microwave irradiation at a frequency of 2.45 GHz were investigated. Using ball milling and sieve fractioning, the crystalline drug celecoxib (CCX) and the polymer polyvinylpyrrolidone (PVP) were divided into two particle size fractions, i.e. small (<71 µm) and large (>71 µm) particles. Subsequently, compacts containing a drug load of 30% (w/w) crystalline CCX in PVP were prepared and subjected to microwave radiation for an accumulated duration of 600 sec in intervals of 60 sec as well as continuously for 600 sec. It was found that the compacts containing small CCX particles displayed faster rates of amorphization and a higher degree of amorphization during microwave irradiation as compared to the compacts containing large CCX particles. For compacts with small CCX particles, interval exposure to microwave radiation resulted in a maximum degree of amorphization of 24%, whilst a fully amorphous solid dispersion (100%) was achieved after 600 sec of continuous exposure to microwave radiation. By monitoring the temperature in the core of the compacts during exposure to microwave radiation using a fiber optic temperature probe, it was found that the total exposure time above the glass transition temperature (T) was shorter for the interval exposure method compared to continuous exposure to microwave radiation. Therefore, it is proposed that the in situ formation of an amorphous solid dispersion is governed by the dissolution of drug into the polymer, which most likely is accelerated above the T of the compacts. Hence, prolonging the exposure time above the T, and increasing the surface area of the drug by particle size reduction will increase the dissolution rate and thus, rate and degree of amorphization of CCX during exposure to microwave radiation.

摘要

在这项研究中,研究了药物和聚合物粒径对 2.45GHz 微波辐射原位非晶化的影响。通过球磨和筛分,将结晶药物塞来昔布(CCX)和聚合物聚乙烯吡咯烷酮(PVP)分为两个粒径部分,即小(<71μm)和大(>71μm)颗粒。随后,制备了含有 30%(w/w)结晶 CCX 的药物负载 PVP 压块,并在间隔 60 秒的情况下进行 600 秒的微波辐射,以及连续进行 600 秒的微波辐射。结果发现,与含有大 CCX 颗粒的压块相比,含有小 CCX 颗粒的压块在微波辐射下显示出更快的非晶化速率和更高的非晶化程度。对于含有小 CCX 颗粒的压块,间隔暴露于微波辐射导致最大非晶化程度为 24%,而在连续暴露于微波辐射 600 秒后,实现了完全非晶固体分散体(100%)。通过使用光纤温度探头监测压块在暴露于微波辐射期间核心的温度,发现间隔暴露于微波辐射的总暴露时间高于玻璃化转变温度(T)比连续暴露于微波辐射要短。因此,提出了原位形成无定形固体分散体是由药物溶解到聚合物中控制的,这很可能在压块的 T 以上加速。因此,延长 T 以上的暴露时间,并通过粒径减小增加药物的表面积,将增加药物的溶解速率,从而在暴露于微波辐射时增加 CCX 的溶解速率和非晶化程度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验